drug discovery

338 projects

H2020Individual fellowship2017–2019Israel

DUBs26S · Role of a novel proteasome-associated DUB – A boon for therapeutics

H2020Individual fellowship2017–2019France

HBVssNMR · Investigating the structural role of the Hepatitis B virus core protein C-terminal domain in assembly and maturation using solid-state NMR

H2020Individual fellowship2017–2019France

FimH-Mech · The molecular mechanism of E. coli FimH pathogenicity

H2020Individual fellowship2017–2019Germany

LIsTEN · β-Lactams as flaviviral NS3 protease inhibitors

H2020Individual fellowship2017–2019United Kingdom

IVORIaN · RAS/C-RAF interaction: A new pharmacological target in Kras-driven lung cancer.

H2020Individual fellowship2017–2019United Kingdom

Glyco-Platforms · Novel smart glyco-nanomaterials as targeted therapeutics.

H2020Individual fellowship2017–2019Sweden

PCAGED-KI · Photocaged Kinase Inhibitors as Molecular Tools for Investigating Neurodegenerative Diseases

H2020Individual fellowship2017–2019Spain

FRAGMENTOME · FRAGMENT screening from advanced-sampling molecular dynamics simulations on a proteOME scale.

H2020Individual fellowship2017–2019Belgium

RHOMBOSMALPS · Enabling malaria rhomboid proteases as drug targets: usage of molecular cookie cutters to shape novel activity assays and inhibitors.

H2020Individual fellowship2017–2019United Kingdom

ACTPD · Streamlined Functionalisation of Nitrogen-containing Molecules by Palladium-catalysed C-H Activation

H2020Individual fellowship2017–2019Germany

OMICS · Origami-based Microfluidic Interface for Cell Signalling

H2020Doctoral network2017–2021United Kingdom

FLUDD · Late Stage Fluorination and its Applications to Drug Discovery

2 partners · 2 countries

H2020Individual fellowship2017–2019Ireland

COEXIST · Confined, Optically Enhanced, X-ray Imaging Source for Tomography

H2020Staff exchange2017–2020Ireland

Halo · Development and Application of a New Class of Halogenated Reagents to Commercially Valuable Targets

4 partners · 4 countries

H2020Doctoral network2017–2021Sweden

GlycoImaging · Imaging and detection of tumor-associated glycan structures on tumor cells

6 partners · 4 countries

H2020Individual fellowship2017–2018Italy

URBACH-ALZ · Hyper-emotionality after neurodegenerative loss of inhibition of the amygdala

2 partners · 2 countries

H2020Staff exchange2017–2022Ireland

3D NEONET · Drug Discovery and Delivery NEtwork for ONcology and Eye Therapeutics

22 partners · 7 countries

H2020Staff exchange2017–2021Ireland

INSPIRED · Targeting IRE1 in disease

9 partners · 7 countries

H2020Doctoral network2017–2021United Kingdom

TransPot · Translational Research Network in Prostate Cancer

17 partners · 6 countries

H2020Doctoral network2017–2021United Kingdom

MMBio · Molecular Tools for Nucleic Acid Manipulation for Biological Intervention

19 partners · 7 countries

H2020Doctoral network2017–2020Italy

Train2Target · An integrated mulTidisciplinary appRoach towards a new generAtIon of aNtibiotics: Targeting function and cross-talk of bacterial Envelope proTein machineries

17 partners · 8 countries

H2020Doctoral network2017–2021Portugal

Foie Gras · Bioenergetic Remodeling in the Pathophysiology and Treatment of Non-Alcoholic Fatty Liver Disease

14 partners · 8 countries

H2020Doctoral network2017–2020Finland

PRINT-AID · Multidisciplinary European training network for development of personalized anti-infective medical devices combining printing technologies and antimicrobial functionality

13 partners · 7 countries

H2020Individual fellowship2017–2019Denmark

EpiTarget · Epigenome-targeted therapy for cholangiocarcinoma.